12 Matching Annotations
  1. Sep 2025
  2. dx.doi.org dx.doi.org
    RACK1 is required for normal B cell development and signaling but not RAG1 degradation
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    dx.doi.org/10.1093/jimmun/vkaf217
  3. Mar 2025
  4. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Paving the way for better ototoxicity assessments in cisplatin therapy using more reliable animal models
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC11919870/
  5. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Lmx1a is essential for marginal cell differentiation and stria vascularis formation
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC11920146/
  6. Aug 2024
  7. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Oseltamivir (Tamiflu), a commonly prescribed antiviral drug, mitigates hearing loss in mice
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC11318337/
  8. Jul 2024
  9. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    ERK1/2 Inhibition via the Oral Administration of Tizaterkib Alleviates Noise-Induced Hearing Loss While Tempering down the Immune Response
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC11204379/
  10. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Trametinib, a MEK1/2 Inhibitor, Protects Mice from Cisplatin- and Noise-Induced Hearing Loss
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC11206450/
  11. May 2024
  12. www.biorxiv.org www.biorxiv.org
    FDA-Approved MEK1/2 Inhibitor, Trametinib, Protects Mice from Cisplatin and Noise-Induced Hearing Loss
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    biorxiv.org/content/10.1101/2024.05.20.595056v1
  13. www.biorxiv.org www.biorxiv.org
    Oseltamivir (Tamiflu), a Commonly Prescribed Antiviral Drug, Mitigates Hearing Loss in Mice
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    biorxiv.org/content/10.1101/2024.05.06.592815v1
  14. www.jneurosci.org www.jneurosci.org
    KSR1 Knockout Mouse Model Demonstrates MAPK Pathway’s Key Role in Cisplatin- and Noise-induced Hearing Loss
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    jneurosci.org/content/44/18/e2174232024
  15. Jan 2024
  16. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Dabrafenib protects from cisplatin-induced hearing loss in a clinically relevant mouse model
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC10807719/
  17. Dec 2023
  18. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    KSR1 Knockout Mouse Model Demonstrates MAPK Pathway's Key Role in Cisplatin- and Noise-induced Hearing Loss
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC10680565/
  19. Oct 2023
  20. www.biorxiv.org www.biorxiv.org
    ERK1/2 Inhibition Alleviates Noise-Induced Hearing Loss While Tempering Down the Immune Response
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    biorxiv.org/content/10.1101/2023.10.18.563007v1